...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Free
Message: Resverlogix Reports Positive FDA Type B Meeting on Design Issues Relating to a Proposed Phase 2a Kidney Dialysis Trial

Bear, The only difference I see between the new PK study and the New Zealand PK study is that the new one will be with people on dialysis where the New Zealand one was with stage 4 patients not on dialysis.

Share
New Message
Please login to post a reply